Navigation Links
arGEN-X Appoints Alain Thibault as Chief Medical Officer and Koos Rasser as IP Counsel
Date:3/19/2012

ROTTERDAM, the Netherlands and GHENT, Belgium, March 19, 2012 /PRNewswire/ --

arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody™ platform, announces today that it has strengthened its management team with two key hires. Alain Thibault, MD joins the Company as Chief Medical Officer, while Jacobus (Koos) Rasser, PhD, JD will serve as IP Counsel.

Dr. Alain Thibault has gained a wealth of clinical development experience in oncology, both in the US and Europe, in a career spanning more than 15 years. Prior to joining arGEN-X, Dr.Thibault was therapeutic area head of Oncology at Regeneron Pharmaceuticals where he was responsible for clinical development, product strategy and portfolio management, as well as coordination of the collaboration with Sanofi to develop fully human antibody products for multiple cancer indications. While at Regeneron, Dr. Thibault led the clinical development of VEGF Trap (aflibercept) as well as the fully human antibody products REGN 421 and REGN 910. Dr. Thibault has extensive clinical development expertise across all stages of biopharmaceutical clinical development, having previously held senior research positions at Johnson & Johnson and Hoffman-La Roche before joining Regeneron.

Koos Rasser, PhD, JD brings over 30 years of experience in the development and commercialization of global intellectual property portfolios. Before joining arGEN-X, Dr. Rasser was senior partner at the global IP law firm Howrey LLP and founded its London practice. Among his clients in the pharma/biotech field were Biogen Idec, Millennium Pharmaceuticals, Eppendorf, Schering Plough and Amersham. He also acted as interim IP Director at Akzo Nobel's Organon Division. Prior to his tenure at Howrey, Dr. Rasser was head of the global IP organization at Procter & Gamble, where he was responsible for a portfolio of more than 2,000 patent fami
'/>"/>

SOURCE arGEN-X
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. arGEN-X Concludes EUR 12.5 Million Series A Financing Round
2. arGEN-X SIMPLE Antibody(TM) Platform set to Transform Therapeutic Antibody Discovery & Development
3. arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform
4. arGEN-X Announces Non-Exclusive License With BioWa for POTELLIGENT® Technology
5. arGEN-X Presents Significant Progress at BioPharm America 2011
6. arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B Round
7. Argen-X Launches NHance™ Technology to Generate Better Human Antibody Therapies
8. Quark Pharmaceuticals Appoints New Chief Medical Officer
9. West Pharmaceutical Services, Inc. Appoints New Director
10. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
11. Curemark Appoints Preeminent Pediatrics Gastroenterologist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  Air Products (NYSE: ... of medical oxygen is vital to any healthcare facility. ... that not only improve the efficiency of its oxygen ... will highlight these systems—including systems for emergency oxygen ... loss—from August 4-5 at the 51 st ...
(Date:7/28/2014)... July 28, 2014  VigeneTech, Inc, in collaboration ... LEGENDplex™ Data Analysis Software, an OEM software solution ...  BioLegend develops and offers varieties of bead-based multi-analyte ... the support of VigeneTech,s data analysis software, FCS ... and easily reported LEGENDplex™ software ...
(Date:7/28/2014)...  UBM Medica US announces that Diagnostic ... imaging professionals, explored the complex situation regarding measuring ... The shift from fee-for-service has left radiology at ... is determined in the new payment model . ... field, who recognized the complexity of the radiologist,s value: ...
Breaking Medicine Technology:Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 3VigeneTech Releases New Powerful Software for Flow Cytometry Data Analysis 2Diagnostic Imaging Delves into Measuring the Radiologist's Value 2
... drug candidate may help patients with Systemic Lupus Erythematosus ... ... SAN FRANCISCO, Calif., April 29 Rigel,Pharmaceuticals, Inc. (Nasdaq: RIGL ... lupus prone mice and,significantly improved their survival as reported in a ...
... Terumo Heart, Inc. announced,a presentation at ... presentation,entitled "Long Term Circulatory Support with the ... Patients Eligible for,Transplantation: European Experience" was delivered ... for Terumo Heart, Inc., (Photo: ...
Cached Medicine Technology:Rigel's R788 Slows Progression of Murine Lupus in Preclinical Studies 2Rigel's R788 Slows Progression of Murine Lupus in Preclinical Studies 3Rigel's R788 Slows Progression of Murine Lupus in Preclinical Studies 4Terumo Heart Summarizes Results of DuraHeart(TM) LVAS Implants 2
(Date:7/28/2014)... are on the cusp of revolutionizing health care, armed ... from cardiac measurements to sonograms. , While tremendous potential ... costs, several health law experts say in a just-published ... that more oversight is needed by the U.S. Food ... safety. Out of some 100,000 mHealth apps on the ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 According ... Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition ... ALD), Product (Power, Opto-electronic), Application, and Geography-2013-2020", published ... at a CAGR of 12.63% from 2014 to ... Browse 121 market data tables and 88 figures ...
(Date:7/28/2014)... July 28, 2014 According to a ... Solution Software Market- Global Industry Analysis, Size, Share, Growth, ... device market was valued at USD 3,005 million in ... of 13.8% from 2014 to 2020, to reach an ... Globally, the e-clinical solution software market is witnessing significant ...
(Date:7/28/2014)... in Taiwan has developed a new optical technology that ... diabetes sooner, when it is more easily treated. If ... it may pave the way for the early detection ... autonomic neuropathy, which is common among people with both ... affects the autonomic nerves controlling vital organs like the ...
(Date:7/28/2014)... Axiom EPM , a leading ... performance management software for enterprises, today announced that it ... that surpassed its record Q1 results, and adding more ... this growth to increased demand for its comprehensive suite ... addition of incremental solutions for existing customers. New clients ...
Breaking Medicine News(10 mins):Health News:Booming mobile health app market needs more FDA oversight for consumer safety, confidence 2Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 2Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 3Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 4Health News:Global E-Clinical Solution Software Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Health News:Global E-Clinical Solution Software Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Health News:Global E-Clinical Solution Software Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 4Health News:Wearable device for the early detection of common diabetes-related neurological condition 2Health News:Axiom EPM Announces Record Second Quarter of 2014 2
... seems to be reaching epidemic proportions, forcing changes in ... are now revamping their fleet of ambulances to cope ... ,Super-sized vehicles have been introduced and new air ... ambulances will now be equipped with heavy-duty stretchers, capable ...
... has approved four new drugs manufactured by the Macleods of ... of the four would be used against some strains of ... these four medicines will reinforce efforts to scale up access ... a statement. ,The medicines are the first TB ...
... While it is well known that genetics and family history ... lifestyle choices which include diet//, exercise and environment, do play ... session of the American College of Cardiology looked at many ... person’s chances of being diagnosed with heart disease. ...
... claim that they can efficiently seek out and kill ... very similar to the Nature's way of distinguishing one ... tumor targeting strategy, presented today (March 25) at the ... harnesses one of the body's natural antibodies and immune ...
... has sought for more organ donations so as to meet ... According to him there is a big gap between the ... ,Statistics reveal that 1.5 million patients need organ transplants each ... In China organs are donated by people after signing voluntary ...
... all mental health units in England and Wales revealed ... This is much against the government’s claim that this ... ,The healthcare commission reports that 55% of in-patients are ... opposite sex. This practice has resulted in an increase ...
Cached Medicine News:Health News:Indian Pharma Authorized to Market New Anti-TB Drugs 2Health News:Role of Lifestyle Choices in Heart Risks 2Health News:Role of Lifestyle Choices in Heart Risks 3Health News:Tumors Targeted Naturally 2Health News:Tumors Targeted Naturally 3
... innovative Mesh Cathode of the OsteoGen™-M ... and a scaffolding effect designed to ... fracture ends in the management of ... product particularly appropriate for high-risk patients ...
... implanted bone growth stimulator is a useful adjunct ... already planned or when patient compliance may be ... implanted, patients are assured of therapeutic treatment directly ... for up to 6 months. , ,The OsteoGen ...
Our products, with carefully researched design features, are tailored to making arthroscopic and ligament reconstructive surgery more reproducible, easier, quicker and safer....
... Interference Screw has unique, double-helix ... while limiting veering and divergence. ... abrasion where it is most ... thread enables screws to be ...
Medicine Products: